National Uptake and Case Studies
Uptake of jointly produced HTA information
As part of the implementation network, EUnetHTA collects information about the use of its jointly produced HTA information. The information is collected through surveys and interviews carried out with implementation network participants.
Find implementation reports HERE
EUnetHTA partners should provide information about the use of jointly produced HTA information using the implementation feedback survey on the Intranet. Non-EUnetHTA partners can report use to the National Uptake lead agency (firstname.lastname@example.org) at the password-protected feedback survey.
The graphics below show the use of the EUnetHTA JA3 and JA2 assessments. Click on graphic to go to more detailed page of information about implementation for that assessment.
Countries reporting use of at least one JA3 PT assessment
Countries reporting use of at least one JA3 OT assessment
OTCA23 (Biodegradable rectum spacers)
OTCA22 (Point of Care Tests D-Dimer and Troponin)
OTCA19 (Screening for Osteoporosis)
OTCA18 (Regional hyperthermia)
OTCA17 (Lithium triborate)
OTCA16 (Bioresorbable stents)
OTCA15 (Irreversible Electroporation)
OTCA14 (Robot-Assisted Surgery)
OTCA12 (CRP POCT)
OTCA11 (3D Printed Implants)
OTJA10 (Stool DNA Testing)
OTCA09 (HIFU Ablation)
OTJA08 (Glucose Monitoring)
OTCA05 (Magnetic Stimulation)
OTCA02 (Antibacterial-coated Sutures)
OTCA01 (Wearable Cardioverter-defibrillator)